Skip to main content
. 2016 Oct 27;2(4):425–432. doi: 10.3233/BLC-160067

Fig.2.

Fig.2

Patients with a response to neoadjuvant treatment had a significantly prolonged overall survival in comparison to non-reponders, p = 0.01.